ConductScience.org, home

Paper41337883

As48, a first-in-class dual-function TREM2 modulator: Receptor activation and shedding inhibition.

Cho S and 5 others. Biomed Pharmacother, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. As48, a first-in-class dual-function TREM2 modulator: Receptor activation and shedding inhibition. Papers, record 41337883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41337883

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
As48, a first-in-class dual-function TREM2 modulator: Receptor activation and shedding inhibition.
PubMed
Journal
Biomed Pharmacother
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-01-29
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cho SSungwoo
2El Gaamouch FFarida
3Upadhyay SSaurabh
4Nada HHossam
5Kuncewicz KKatarzyna
6Gabr MTMoustafa T

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptors, ImmunologicMajor topic
Membrane GlycoproteinsMajor topic
Humans
Molecular Docking Simulation
Molecular Dynamics Simulation
Microglia
Animals
Phagocytosis
HEK293 Cells
Phosphorylation
ADAM17 Protein

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AG083512NIA NIH HHSUnited StatesR01AG083512PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of40909719

Source PubMed

Download CSV of comments and corrections

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123623698Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.Neuron2013https://conductscience.org/library/papers/23623698PubMed
233507843Novel ligands and modulators of triggering receptor expressed on myeloid cells receptor family: 2015-2020 updates.Expert Opin Ther Pat2021https://conductscience.org/library/papers/33507843PubMed
328930663The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.Immunity2017https://conductscience.org/library/papers/28930663PubMed
440080100Impact of Cancer-Associated PKM2 Mutations on Enzyme Activity and Allosteric Regulation: Structural and Functional Insights into Metabolic Reprogramming.Biochemistry2025https://conductscience.org/library/papers/40080100PubMed
532531244The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway.Cell2020https://conductscience.org/library/papers/32531244PubMed
612667689High throughput artificial membrane permeability assay for blood-brain barrier.Eur J Med Chem2003https://conductscience.org/library/papers/12667689PubMed
738981007Microglia Gravitate toward Amyloid Plaques Surrounded by Externalized Phosphatidylserine via TREM2.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38981007PubMed
828432014TREM2-Ligand Interactions in Health and Disease.J Mol Biol2017https://conductscience.org/library/papers/28432014PubMed
920067834Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.Eur J Pharm Biopharm2010https://conductscience.org/library/papers/20067834PubMed
1028602351A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease.Cell2017https://conductscience.org/library/papers/28602351PubMed
1139269728Discovery of ICOS-Targeted Small Molecules Using Affinity Selection Mass Spectrometry Screening.ChemMedChem2024https://conductscience.org/library/papers/39269728PubMed
1232955158Affinity selection-mass spectrometry for the discovery of pharmacologically active compounds from combinatorial libraries and natural products.J Mass Spectrom2021https://conductscience.org/library/papers/32955158PubMed
1330266932TREM2 - a key player in microglial biology and Alzheimer disease.Nat Rev Neurol2018https://conductscience.org/library/papers/30266932PubMed
1436635496A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer's disease models.Nat Neurosci2023https://conductscience.org/library/papers/36635496PubMed
1526911435TREM2 variants: new keys to decipher Alzheimer disease pathogenesis.Nat Rev Neurosci2016https://conductscience.org/library/papers/26911435PubMed
1629518356TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function.Neuron2018https://conductscience.org/library/papers/29518356PubMed
1740663973CHI3L1-targeted small molecules as glioblastoma therapies: Virtual screening-based discovery, biophysical validation, pharmacokinetic profiling, and evaluation in glioblastoma spheroids.Eur J Med Chem2025https://conductscience.org/library/papers/40663973PubMed
1825728668TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model.Cell2015https://conductscience.org/library/papers/25728668PubMed
1933833439The cGAS-STING pathway as a therapeutic target in inflammatory diseases.Nat Rev Immunol2021https://conductscience.org/library/papers/33833439PubMed
2038762085Coupling of surface plasmon resonance and mass spectrometry for molecular interaction studies in drug discovery.Drug Discov Today2024https://conductscience.org/library/papers/38762085PubMed

See all 43 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42812614TREM2-directed therapy in Alzheimer's disease: from therapeutic window to clinical translation.Front Aging Neurosci2026https://conductscience.org/library/papers/42812614PubMed
42445022High-Throughput CETSA Identifies Small Molecule Modulators of ILT3 (LILRB4) with Functional Activity in Human iPSC-Derived Microglia for Alzheimer's Disease.ACS Med Chem Lett2026https://conductscience.org/library/papers/42445022PubMed
41998699Triggering receptor expressed on myeloid cell family in atherosclerosis: from mechanisms to intervention strategies.Cell Commun Signal2026https://conductscience.org/library/papers/41998699PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
SYK6850PubTator's text mininghttps://conductscience.org/library/genes/6850NCBI Gene
TREM154210PubTator's text mininghttps://conductscience.org/library/genes/54210NCBI Gene
TREM254209PubTator's text mininghttps://conductscience.org/library/genes/54209NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41337883

GET https://conductscience.org/api/papers/v1/41337883/references?page=2